Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05293106 · ClinicalTrials.gov registry record · Phase 4
Assessing the Hemostatic Efficacy of Pathogen Reduced Platelets in Children Undergoing Cardiopulmonary Bypass Surgery: A Pilot Clinical Trial
A Phase 4 study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 9
- Enrollment target
NCT05293106 is a Phase 4 study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 9 participants.
The verdict
NCT05293106, a Phase 4 study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 9 participants
- Enrollment target
Study Summary
This study is testing whether pathogen reduced platelets can control bleeding as well as non-pathogen reduced platelets (otherwise known as large volume delayed sampling).
Interventions
- BIOLOGICAL Platelet Transfusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2022-07-05 |
| Est. Completion | 2023-09-27 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05293106
The ClinicalTrials.gov registry entry for NCT05293106 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Platelet Transfusion is the first listed.
NCT05293106 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05293106 about?
NCT05293106 is a clinical study titled "Assessing the Hemostatic Efficacy of Pathogen Reduced Platelets in Children Undergoing Cardiopulmonary Bypass Surgery: A Pilot Clinical Trial". This study is testing whether pathogen reduced platelets can control bleeding as well as non-pathogen reduced platelets (otherwise known as large volume delayed sampling).
What is the current status of trial NCT05293106?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 9 participants. The study started on 2022-07-05. Estimated completion is 2023-09-27.
What interventions are being tested in trial NCT05293106?
The interventions under investigation include: Platelet Transfusion (BIOLOGICAL).
Who is sponsoring clinical trial NCT05293106?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.